Читать книгу Clinical Pancreatology for Practising Gastroenterologists and Surgeons - Группа авторов - Страница 26

1 1 Gapp J, Hall AG, Walters RW, et al. Trends and outcomes of hospitalizations related to acute pancreatitis. Epidemiology from 2001 to 2014 in the United States. Pancreas 2019; 48(4):548–554.

2 2 Afghani E, Pandol SJ, Shimosegawa T, et al. Acute pancreatitis: progress and challenges. A report on an international symposium. Pancreas 2015; 44:1195–1210.

3 3 Roberts SE, Morrison‐Rees S, John A, et al. The incidence and etiology of acute pancreatitis across Europe. Pancreatology 2017; 17:155–165.

4 4 Brindise E, Elkhatib I, Kuruvilla A, Silva R. Temporal trends in incidence and outcomes of acute pancreatitis in hospitalized patients in the United States. Pancreas 2019; 48:169–175.

5 5 Krishna SG, Kamboj AK, Hart PA, et al. The changing epidemiology of acute pancreatitis hospitalizations: a decade of trends and the impact of chronic pancreatitis. Pancreas 2017; 46:482–488.

6 6 Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver and pancreatic diseases in the United States: Update 2018. Gastroenterology 2019; 156:254–272.

7 7 Barkin JA, Nemeth Z, Saluja AK, Barkin JS. Cannabis‐induced acute pancreatitis: a systematic review. Pancreas 2017; 46:1035–1038.

8 8 Ardengh JC, Malheiros CA, Rahl F, et al. Microlithiasis of the gallbladder: role of endoscopic ultrasonography in patients with idiopathic pancreatitis. Rev Assoc Med Bras 2010; 56(1):27–31.

9 9 Vila JJ. Endoscopic ultrasonography and idiopathic acute pancreatitis. World J Gastrointest Endosc 2010; 2:107–111.

10 10 Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post‐ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102:1781–1788.

11 11 Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70:80–88.

12 12 Buxbaum JL, Abbas Fehmi SM, Sultan S, et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc 2019; 89(6):1075–1105.e15.

13 13 De Lisi S, Leandro G, Buscarini E. Endoscopic ultrasonography versus endoscopic retrograde cholangiopancreatography in acute biliary pancreatitis: a systematic review. Eur J Gastroenterol Hepatol 2011; 23:367–374.

14 14 Makary MA, Duncan MD, Harmon JW, et al. The role of magnetic resonance cholangiography in the management of patients with gallstone pancreatitis. Ann Surg 2005; 241:119–124

15 15 Wan J, Ouyang Y, Yu C, et al. Comparison of EUS with MRCP in idiopathic acute pancreatitis: a systematic review and meta‐analysis. Gastrointest Endosc 2018; 87:1180–1188.

16 16 Wilcox CM, Varadarajulu S, Eloubeidi M. Role of endoscopic evaluation in idiopathic pancreatitis: a systematic review. Gastrointest Endosc 2006; 63:1037–1045.

17 17 Kondo S, Isayama H, Akahane M, et al. Detection of bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography and helical‐computed‐tomography cholangiography. Eur J Radiol 2005; 54:271–275.

18 18 Savides TJ. EUS‐guided ERCP for patients with intermediate probability for choledocholithiasis: is it time for all of us to start doing this? Gastrointest Endosc 2008; 67:669–672.

19 19 Khatua B, El Kurdi B, Singh VP. Obesity and pancreatitis. Curr Opinion Gastroenterol 2017; 33:374–382.

20 20 Camilleri M, Malhi H, Acosta A. Gastrointestinal complications of obesity. Gastroenterology 2017; 152(7):1656–1670.

21 21 Dobszai D, Mάtrai, Erỡss B, et al. Body‐mass index correlates with severity and mortality in acute pancreatitis: a meta‐analysis. World J Gastroenterol 2019; 25:729–743.

22 22 Natu A, Stevens T, Kang L, et al. Visceral adiposity predicts severity of acute pancreatitis. Pancreas 2017; 46:776–781.

23 23 Choi JS, Yi S‐W, Park JW, et al. Body mass index and the risk of acute pancreatitis by etiology: a prospective analysis of Korean National Screening Cohort. J Gastroenterol Hepatol 2019; 34(3):603–611.

24 24 Molitch ME. Diabetes mellitus. In: Walker HK, Hall WD, Hurst JW (eds) Clinical Methods: The History, Physical and Laboratory Examinations, 3rd edn. Boston: Butterworths, 1990, chapter 136.

25 25 Albai O, Roman D, Frandes M, et al. Hyperglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus. Ther Clin Risk Manag 2017; 13:515–522.

26 26 Garg R, Rustagi T. Management of hypertriglyceridemia‐induced acute pancreatitis. BioMed Res Int 2018; 2018:4721357.

27 27 Yin G, Cang X, Yu G, et al. Different clinical presentations of hyperlipidemic acute pancreatitis: a prospective study. Pancreas 2015; 44:1105–1110.

28 28 Elkouly MA, Salazar MJ, Simons‐Linares R. Hypertriglyceridemia‐associated drug‐induced acute pancreatitis. Pancreas 2019; 48(1):22–35.

29 29 Pedersen SB, Langsted A, Nordestgaard BG. Non‐fasting mild‐to‐moderate hyperglyceridemia and risk of acute pancreatitis. JAMA Intern Med 2016; 176(12):1834–1842.

30 30 Vipperla K, Sommerville C, Furlan A et al. Clinical profile and natural course in a large cohort of patients with hypertriglyceridemia and pancreatitis. J Clin Gastroenterol 2017; 51:77–85.

31 31 Wang Q, Wang G, Qiu Z, et al. Elevated serum triglycerides in the prognostic assessment of acute pancreatitis. A systematic review and meta‐analysis of observational studies. J Clin Gastroenterol 2017; 51:586–593

32 32 Sue LY, Batech M, Yadav D, et al. Effect of serum triglycerides on clinical outcomes in acute pancreatitis: findings from a regional integrated health care system. Pancreas 2017; 46:874–879.

33 33 Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol 2015; 110:1497–1503.

34 34 Zafrir B, Saliba W, Jubran A, et al. Severe hypertriglyceridemia‐related pancreatitis: characteristics and predictors of recurrence. Pancreas 2019; 48:182–186.

35 35 Preiss D, Tikkanen, MJ, Welsh P. et al. Lipid‐modifying therapies and risk of pancreatitis. JAMA 2012; 308(8):804–811.

36 36 Raphael KL, Wellingham FF. Hereditary pancreatitis: current perspectives. Clin Exp Gastroenterol 2016; 9:197–207.

37 37 Jalaly NY, Moran RA, Fargahi F, et al. An evaluation of factors associated with pathogenic PRSS1, SPINK1, CTFR, and/or CTRC genetic variants in patients with idiopathic pancreatitis. Am J Gastroenterol 2017; 112:1320–1329.

38 38 Hasan A, Moscoso DI, Kastrinos F. The role of genetics in pancreatitis. Gastrointest Endosc Clin North Am 2018; 28:587–603.

39 39 Weiss FU, Hasselbarth N, Párniczky, et al. Common variants in the CLDN2‐MORC4 and PRSS1‐PRSS2 loci confer susceptibility to acute pancreatitis. Pancreatology 2018; 18:477–481.

40 40 Lindkvist B, Appelros S, Manjer J, et al. A prospective cohort study of smoking in acute pancreatitis. Pancreatology 2008; 8(1):63–70.

41 41 Talukdar R, Vege SS. Recent developments in acute pancreatitis. Clin Gastroenterol Hepatol 2009; 7(11 Suppl):S3–S9.

42 42 Tenner S. Drug‐induced acute pancreatitis: does it exist? World J Gastroenterol 2014; 20(44):16529–16534.

43 43 Meczker A, Miko A, Gede N et al. Retrospective matched‐cohort analysis of acute pancreatitis induced by 5‐aminosalicylic acid‐derived drugs. Pancreas 2019; 48:488–495.

44 44 Munigala S, Kanwai F, Xian H, et al. Increased risk of pancreatic adenocarcinoma after acute pancreatitis. Clin Gastroenterol Hepatol 2014; 12:1143–1150.

45 45 Chung S‐D, Chen K‐Y, Xirasagar S, et al. More than 9‐times increased risk for pancreatic cancer among patients with acute pancreatitis in Chinese population. Pancreas 2012; 41:142–146.

46 46 Diaz LI, Li Y, Barkin JS. Natural history of spontaneous rupture of a pancreatic pseudocyst into the peritoneal cavity and its minimal noninvasive management. Pancreas 2019; 48(4):e20–e21.

47 47 Kiriyama S, Gabata T, Takada T, et al. New diagnostic criteria of acute pancreatitis. J Hepatobiliary Pancreat Sci 2010; 17:24–36.

48 48 Ismail OZ, Bhayana V. Lipase or amylase for the diagnosis of acute pancreatitis? Clin Biochem 2017; 50:1275–1280.

49 49 Working Group IAP/APA Pancreatitis Guidelines. IAP/APA evidence‐based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13(4 Suppl 2):e1–e15.

50 50 Tṻrkvatan A, Erden A, Tṻrkoglu et al. Imaging of acute pancreatitis and its complications. Part 1: Acute pancreatitis. Diagn Interv Imaging 2015; 96:151–163.

51 51 Jang JW, Kim M‐H, Oh D, et al. Factors and outcomes associated with pancreatic duct disruption in patients with acute necrotizing pancreatitis. Pancreatology 2016; 16:958–965.

52 52 Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med 2016; 375:1972–1981.

53 53 Di M‐Y, Liu H, Yang Z‐Yet al. Prediction models of mortality in acute pancreatitis in adults. Ann Intern Med 2016; 165:482–490.

54 54 Wu BU. Prognosis in acute pancreatitis. Can Med Assoc J 2011; 183:673–677.

55 55 Singh V, Wu B, Bollen T, et al. A prospective evaluation of the bedside Index Severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol 2009; 104:966–971.

56 56 Singh VK, Wu BU, Bollen TL et al. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis. Clin Gastroenterol Hepatol 2009; 7:1247–1251.

57 57 Koutroumpakis E, Wu BU, Bakker OJ, et al. Admission hematocrit and rise in blood urea nitrogen at 24 h outperform other laboratory markers in predicting persistent organ failure and pancreatic necrosis in acute pancreatitis: a post hoc analysis of three larger prospective databases. Am J Gastroenterol 2015; 110:1707–1716.

58 58 Forsmark CE, Yadav D. Predicting the prognosis of acute pancreatitis. Ann Intern Med 2016; 165(7):523–524.

59 59 Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis, 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62:102–111.

60 60 Singh VK, Bollen TL, Bechien U et al. An assessment of the severity of interstitial pancreatitis. Clin Gastroenterol Hepatol 2011; 9:1098–1103.

61 61 Vege SS, DiMagno MJ, Forsmark CE, et al. Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute Technical Review. Gastroenterology 2018; 154:1103–1139.

62 62 Sinha A, Vazquez NQ, Faghih M, et al. Early predictors of fluid sequestration in acute pancreatitis. A validation study. Pancreas 2016; 45:306–310.

63 63 De‐Madaria E, Banks PA, Moya‐Hoyo N. Early factors associated with fluid sequestration and outcomes of patients with acute pancreatitis. Clin Gastroenterol Hepatol 2014; 12:997–1002.

64 64 Buxbaum JL, Quezada M, Da B, et al. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am J Gastroenterol 2017; 112:797–803.

65 65 Warndorf MG, Kurtzman JT, Bartel MJ, et al. Early fluid resuscitation reduces morbidity among patients with acute pancreatitis. Clin Gastroentrol Hepatol 2011; 9:705–709.

66 66 Crockett SD, Wani S, Gardner TB. AGA Guidelines on initial management of acute pancreatitis. Gastroenterology 2018; 154:1096–1101.

67 67 Singh VK, Gardner TB, Papachristou GI, et al. An international multicenter study of early intravenous fluid administration and outcomes in acute pancreatitis. United Eur Gastroenterol J 2017; 5(4):491–498.

68 68 Zavyalov T, Khotsyna Y, Tenner S. The role of antibiotics in the management of patients with acute necrotizing pancreatitis. Curr Infect Dis Rep 2010; 12:13–18.

69 69 Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2010;(5):CD002941.

70 70 Adler DG, Chari ST, Dahl TJ, et al. Conservative management of infected necrosis complicating severe acute pancreatitis. Am J Gastroenterol 2003; 98:98–102.

71 71 Runzi M, Niebel W, Goebell H, et al. Severe acute pancreatitis: nonsurgical treatment of infected necroses. Pancreas 2005; 30:195–199.

72 72 Bakker OJ, van Brunschot HC, van Santvoort MG, et al. Early versus on‐demand naso‐enteric tube feeding in acute pancreatitis. N Engl J Med 2014; 371:1983–1993.

73 73 Cote GA. Early enteral feeding does not improve outcomes in patients with predicted severe acute pancreatitis. Gastroenterology 2015; 148:1476–1478.

74 74 Zhao X, Zhu SF, Xue GJ, et al. Early oral refeeding based on hunger in moderate and severe acute pancreatitis: a prospective controlled, randomized clinical trial. Nutrition 2015; 31:171–175.

75 75 Vaughn VM, Shuster D, Rogers MAM, et al. Early versus delayed feeding in patients with acute pancreatitis. A systematic review. Ann Intern Med 2017; 166:883–892.

76 76 Bevan MG, Asrani VM, Bharmal et al. Incidence and predictors of oral feeding intolerance in acute pancreatitis: a systematic review, meta‐analysis and meta regression. Clin Nutr 2017; 36:722–729.

77 77 Khalid I, Doshi P, DiGiovine B. Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Crit Care 2010; 19:261–268.

78 78 Bakker OJ, van Brunschot S, Farre A, et al. Timing of enteral nutrition in acute pancreatitis: meta‐analysis of individuals using a single‐arm of randomized trials. Pancreatology 2014; 14:340–346.

79 79 Jin M, Zhang H, Lu B, et al. The optimal timing of enteral nutrition and its effect on the prognosis of acute pancreatitis: a propensity score matched cohort study. Pancreatology 2017; 17:651–657.

80 80 Petrov MS, van Santvoort HC, Besselink MGH, et al. Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis. Arch Surg 2008; 143(11):1111–1117.

81 81 Munigala S, Subramaniam D, Subramaniam DP, et al. Predictors for early readmission in acute pancreatitis in the United States: a nationwide population‐based study. Pancreatology 2017; 17:534–542.

82 82 Garg SK, Campbell JP, Anugwom C, et al. Incidence and predictors of readmissions in acute pancreatitis. Pancreas 2018; 47:46–54.

83 83 Ali UA, Issa Y, Hagenaars JC, et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after first episode of acute pancreatitis. Clin Gastroenterol Hepatol 2016; 14:738–746.

84 84 Lee PJW, Bhatt A, Holmes J, et al. Decreased severity in recurrent vs. initial episodes of acute pancreatitis. Pancreas 2015; 44:896–900.

85 85 Mallick B, Sharma DJ, Dhaka N et al. Differences between the outcome of recurrent acute pancreatitis and pancreatitis. JGH Open 2018; 2(4):134–138.

86 86 Da Costa DW, Bouwense SA, Schepers NJ, et al. Same‐admission vs. interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multi‐center randomized controlled study. Lancet 2015; 386:1261–1268.

87 87 Lyu Y‐X, Cheng Y‐X, Jin H‐F, et al. Same‐admission vs. delayed cholecystectomy for mild acute biliary pancreatitis: a systematic review and meta‐analysis. BMC Surg 2018; 18:111.

88 88 Bilal M, Kline KT, Trieu J,A et al. Trends in same‐admission cholecystectomy and endoscopic retrograde cholangiopancreatography for acute gallstone pancreatitis: A nationwide analysis across a decade. Pancreatology 2019; 19(4):524–530.

89 89 Krishna SG, Kruger AJ, Patel N, et al. Cholecystectomy during index admission for acute biliary pancreatitis lowers 30‐day readmission rates. Pancreas 2018; 47:996–1002.

90 90 Trust MD, Sheffield KM, Boyd CA, et al. Gallstone pancreatitis in older patients: are we operating enough. Surgery 2011; 150:515–525.

91 91 van Baal MC, Besselink MG, Bakker OJ, et al. Timing of cholecystectomy after mild biliary pancreatitis. A systematic review. Ann Surg 2012; 255:860–866.

92 92 Ridtitid W, Kulpatcharapong S, Piyachaturawat P, et al. The impact of empiric endoscopic biliary sphincterotomy on future gallstone‐related complications in patients with non‐severe acute biliary pancreatitis whose cholecystectomy was deferred or not performed. Surg Endosc 2019; 33(10):3325–3333.

93 93 Bakker OJ, van Santvoort HC, Hagenaars JC, et al. Timing of cholecystectomy after mild biliary pancreatitis. Br J Surg 2011; 98:1446–1454.

94 94 Zargar SA, Mushtag M, Beg MA, et al. Wait‐and‐see policy vs. cholecystectomy after endoscopic sphincterotomy for bile‐duct stones in high‐risk patients with co‐existing gallbladder stones: a prospective randomized trial. Arab J Gastroenterol 2014; 15:24–26.

95 95 Khan MA, Khan Z, Tombazzi CR, et al. Role of cholecystectomy after endoscopic sphincterotomy in the management of choledocholithiasis in high‐risk patients. A systematic review and meta‐analysis. J Clin Gastroenterol 2018; 52:579–589.

96 96 Ventre C, Nowell S, Graham C, et al. Open survival and new‐onset morbidity after critical admission for acute pancreatitis in Scotland: a national electronic healthcare record linkage cohort study. BMJ Open 2018; 8(12):e023853.

97 97 Das SLM, Singh PP, Phillips ARJ, et al. Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta‐analysis. Gut 2014; 63:818–831

98 98 Umapathy C, Raina A, Saligram S, et al. Natural history after acute necrotizing pancreatitis: a large US tertiary care experience. J Gastrointest Surg 2016; 20:1844–1853.

99 99 Shen H‐N, Yang C‐C, Chang Y‐H. Risk of diabetes mellitus after first‐attack acute pancreatitis: a national population‐based study. Am J Gastroenterol 2015; 110:1698–1706.

100 100 Petrov MS. Diabetes of the exocrine pancreas: American Diabetes Association‐compliant lexicon. Pancreatology 2017; 17:523–526.

101 101 Hollemans RA, Hallensleben NDL, Mager DJ, et al for the Dutch Pancreatitis Study group. Pancreatic exocrine insufficiency following acute pancreatitis: systematic review and study level meta‐analysis. Pancreatology 2018; 18:253–262.

102 102 Das SLM, Kennedy JIC, Murphy R, et al. Relationship between the exocrine and endocrine pancreas after acute pancreatitis. World J Gastroenterol 2014; 20:17196–17205.

103 103 Machicado JD, Gougol A, Stello K, et al. Acute pancreatitis has a long‐term deleterious effect on physical health‐related quality of life. Clin Gastroenterol Hepatol 2017; 15:1435–1443.

104 104 Nikkola J, Laukkarinen J, Lahtela J, et al. The long‐term prospective follow‐up of pancreatic function after first episode of acute alcoholic pancreatitis. Recurrence predisposes one to pancreatic dysfunction and pancreatogenic diabetes. J Clin Gastroenterol 2017; 51:183–190.

105 105 Lankisch PG, Breuer N, Bruns A, et al. Natural history of acute pancreatitis: a long‐term population‐based study. Am J Gastroenterol 2009; 104:2797–2805.

106 106 Rijkers AP, Bakker OJ, Ali UA, et al. Risk of pancreatic cancer after a primary episode of acute pancreatitis. Pancreas 2017; 46;1018–1022.

107 107 Sadr‐Azodi O, Oskarsson V, Discacciati A, et al. Pancreatic cancer following acute pancreatitis: a population‐based matched cohort study. Am J Gastroenterol 2018; 113:1711–1719.

108 108 Kirkegard J, Cronin‐Fenton D, Heide‐Jorgensen U, Mortensen FV. Acute pancreatitis and pancreatic cancer risk: a nationwide matched‐cohort study in Denmark. Gastroenterology 2018; 154:1729–1736.

109 109Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144:1252–1261.